Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement

JE Edgar, S Bournazos - Immunological Reviews, 2024 - Wiley Online Library
Advances in antibody technologies have resulted in the development of potent antibody‐
based therapeutics with proven clinical efficacy against infectious diseases. Several …

Microbial lectins as a potential therapeutics for the prevention of certain human diseases

S Bektas, E Kaptan - Life Sciences, 2024 - Elsevier
Lectins are protein or glycoprotein molecules with a specific ability to bind to carbohydrates.
From viruses to mammals, they are found in various organisms and exhibit remarkable …

Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection

K Mader, LB Dustin - Antibodies, 2024 - mdpi.com
The vast majority of antibodies generated against a virus will be non-neutralising. However,
this does not denote an absence of protective capacity. Yet, within the field, there is typically …

[HTML][HTML] Advancements in Antiviral Drug Development: Comprehensive Insights into Design Strategies and Mechanisms Targeting Key Viral Proteins

W Hangyu, L Panpan, S Jie… - … of Microbiology and …, 2024 - pmc.ncbi.nlm.nih.gov
Viral infectious diseases have always been a threat to human survival and quality of life,
impeding the stability and progress of human society. As such, researchers have persistently …

Development: From Traditional to Modern Approaches

M Aribi - New Topics in Vaccine Development, 2024 - books.google.com
Vaccinology, the scientific discipline focused on vaccines, has evolved from com-bating
infectious diseases to addressing a wide array of a broad spectrum of health concerns …